Biosynthetic flux decreases with biosynthetic ability and increases with nutrient flexibility. by Tugce Bilgin (154647)

Transfection of Daoy cells with miR-128a decreases Bmi-1 expression. by Sujatha Venkataraman (194808)

Subjects:

Induced expression of miR-146a decreases NF-κB activation. by Sakthi Priya Selvamani (607420)

Subjects:

Removal of the A-B linker did not decrease PIP₂ affinity. <i>A.-</i> by Paloma Aivar (124885)

Over time, melanization decreases with aging, higher temperature, and infection. by Lindsay E. Martin (17377067)

FFR_CFD decreases with increasing vessel rigidity. by Andy S. C. Yong (2096350)

Chemical Inhibition of eEF1A-1 Peptide Elongation Activity Decreases Palmitate-Induced Cell Death. by Alexandra M. Stoianov (759321)

Increased data compression and variability with decreasing spot TD intensity by Xujing Wang (21247)

CXCL12 expression results in decreased proliferation of PDAC cells. by Ishan Roy (530438)

“…<p>Population growth of adherent GFP and CXCL12-expressing MiaPaCa2 cells was assessed using the Viacount reagent and flow cytometric cell counting (A–B). CXCL12-expressing cells starved for 24 hours and cultured in both 0% serum (A) or 1% serum (B) containing medium were found to have decreased population growth.…”

Primary cilia expression is decreased in preinvasive and invasive prostate cancer. by Nadia B. Hassounah (429199)

Hypoxia dramatically decreased cGMP in cultured porcine retina. by Lorena Olivares-González (3352898)

Novel surfactant lipids decreased in COPD correlating with FEV1. by Christina W. Agudelo (8415171)

Damage accumulation decreases elongation rates and displaces growth equilibrium. by Audrey Menegaz Proenca (845486)

“…<p>All panels depict MG1655 wild-type <i>E</i>. <i>coli</i>. (A) Exposure to phototoxic damage led to decreasing elongation rates in all treatment levels (length of exposure, every 2 min: 70 ms, 700 ms, 1 s, 1.5 s, 3 s). …”

Decreased cell viability and ROS production induced by oxidative treatment. by Sandra M. Martín-Guerrero (780940)

The GHS-R1A antagonist decreases saccharin intake in mice. by Sara Landgren (354407)

Subjects:

The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits - Fig 4 by Jin Zhou (90734)

Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”

The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits - Fig 6 by Jin Zhou (90734)

Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”

The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits - Fig 8 by Jin Zhou (90734)

Subjects: “…prolyl 4- hydroxylase inhibitor GSK 360A decreases post-stroke brain injury…”

Linear regression model with MBI score. by Nadia Yanet Cortés-Álvarez (18611445)

“…Furthermore, the data demonstrated a significant decrease in sBDNF levels in burnout nurses and a negative correlation between BDNF levels and burnout syndrome. …”

Stepwise decrease of NKG2A and acquisition of KIRs is shown by specific markers of NK cell maturation. by Vivien Béziat (204259)